TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Chinese Cancer Drugs Developer InnoCare Raises US$289 Million After Hong Kong IPO Is Nearly 300 Times Oversubscribed
INVESTING

Stemline Stock Doubles After Up to $677M Purchase Accord With Menarini of Italy

PRESS RELEASES

SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.

PRESS RELEASES

Moore Kuehn Encourages TORC, STML, KLXE, And PTLA Investors To Contact Law Firm

PRESS RELEASES

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Stemline Therapeutics, Inc. - STML

PRESS RELEASES

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition Of Stemline Therapeutics Inc.

PRESS RELEASES

Stemline Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Stemline Therapeutics, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm

PRESS RELEASES

Shareholder Alert: Ademi & O'Reilly, LLP Investigates Whether Stemline Therapeutics Inc. Has Obtained A Fair Price In Its Sale To Menarini Group

PRESS RELEASES

(STML) Alert: Johnson Fistel Investigates Proposed Sale Of Stemline Therapeutics; Are Shareholders Getting A Fair Deal?

Chinese Cancer Drugs Developer InnoCare Raises US$289 Million After Hong Kong IPO Is Nearly 300 Times Oversubscribed
INVESTING

Stemline Stock Doubles After Up to $677M Purchase Accord With Menarini of Italy

PRESS RELEASES

Menarini Group To Acquire Stemline Therapeutics In Transaction Valued At Up To $677 Million

PRESS RELEASES

Stemline Therapeutics To Host Conference Call On Fourth Quarter 2019 Financial Results On March 16, 2020

PRESS RELEASES

Stemline Therapeutics To Present At The Cowen 40th Annual Health Care Conference

PRESS RELEASES

STEMLINE THERAPEUTICS, INC. INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Is Investigating Potential Securities Fraud Claims On Behalf Of The Shareholders Of Stemline Therapeutics, Inc.

PRESS RELEASES

Stemline Therapeutics Announces Preliminary 2019 Net Revenues For ELZONRIS® (tagraxofusp) And Highlights Commercial And Clinical Growth Drivers

These 5 Stocks Under $10 Could Explode Up Soon
STOCKS

These 5 stocks under $10 could explode up soon

Tenet Shares Drop as First Quarter Guidance Sinks
STOCKS

Side effect kills cancer patient in Stemline drug trial; company raises money

Trial Patient Dies From a Stemline SL-401 Side Effect
VIDEO

Trial Patient Dies From a Stemline SL-401 Side Effect

Trade These 7 Stocks Under $10 for Huge Profits
OPINION

Trade these 7 stocks under $10 for huge profits

Today's Weak On High Volume Stock: Spirit AeroSystems Holdings (SPR)
MARKETS

Insider Trading Alert - STML, ARCC And PATK Traded By Insiders

Energy Transfer Equity (ETE) Is Today's Dead Cat Bounce Stock
MARKETS

Insider Trading Alert - NXTM, STML And ARCC Traded By Insiders

3 Leisure Stocks Pushing Industry Growth
MARKETS

Insider Trading Alert - STML, DY And KOP Traded By Insiders

Dating Sites: Best, Worst & Weirdest
OPINION

5 Stocks Under $10 Set to Soar

Insider Trading Alert - UVE, WETF And ENPH Traded By Insiders
MARKETS

Insider Trading Alert - ASTE, FINL And STML Traded By Insiders

5 Stocks Insiders Love Right Now
INVESTING

3 Big-Volume Stocks to Trade for Breakouts

5 Hated Earnings Stocks You Should Love
INVESTING

5 Stocks Breaking Out on Unusual Volume